Recently, the latest COVID-19 strain, called Omicron, was discovered in Botswana, Africa, and is believed to be the most serious variant of the virus to date. It has been designated the name “Omicron”, scientific name B.1.1.529. It has attracted global attention, and many countries have closed their borders to relevant regions.
HymonBio’s SARS-CoV-2 test kit reagents derives from excellent testing technology, unaffected by mutations. It has been able to detect Alpha, Beta, Gamma, and Delta strains without fail over the past year, and has obtained recognition from The National Center for Clinical Laboratories, the US FDA NCTR Division of Microbiology, the UK King’s College Hospital NHS Foundation, the Hong Kong Polytechnic University Department of Health, and other official authorities.
Dr. Hua Tsen, co-founder and CTO of HymonBio Co., Ltd., said, “The technical design of the test kit also ensures a 100% detection capacity of VoCs. It is expected to maintain full detection sensitivity of the Omicron strain. Please wait and see.”
Dr. Tammy Tan, co-founder and CEO of HymonBio Co., Ltd., explains, “To catch a snake, catch seven inches of it. And like with the virus, as long as we can grasp it, we can catch it. Our product has not changed its core design since its launch. In the two years since, no matter how the virus has changed, we can always hit the bull’s-eye. I hope our products can help more countries detect the mutant strains in time, take effective measures to control the spread of the epidemic, push back the disease, and save precious human lives.
Post time: Dec-01-2021